ZeoHealth Products is the first skin care product from the company that has been approved by the FDA to treat skin cancer.
The FDA has already approved two other products for use with cancer patients.
The products are named after the animals that are responsible for the growth of tumors and cancer cells.
The first Zeo products is called Zef, and the second Zef is called Ryno.
The Zeo brand is a spinoff of the company Zeo, which is owned by Japanese pharmaceutical giant Eli Lilly.
Zeo has been around since 2007 and was founded by Dr. James F. Ritchie, the son of the famed surgeon who founded the Mayo Clinic.
The company says that they are working with doctors in the U.S. and Europe to develop their next product.
In its latest update, the company said that the Zef skin care products are currently available in the United States and Europe.
It said that it is still testing the effectiveness of the products in treating the disease.
“In addition, we are also developing additional skin care formulations with our innovative technologies in the coming months and will be expanding distribution to Europe and Asia by the end of the year,” it said.
The Zef products are marketed as a treatment for skin cancer and are currently sold by the company through retail channels.
It was founded in 2006 and is based in Tokyo.
The brand was created by Drs.
Ryn and Tomoko Shimamura.
Dr. Rinos first dermatologist husband, Dr. Tomoko is also a dermatologist.
The couple have had three children.
According to the FDA, the Zeo health product is the third-most-expensive skin care in the world.
The product is currently available on the company’s website.
The American dermatologist says that the products can help patients in five stages of the disease: treatment, monitoring, prevention, prevention of recurrence, and maintenance.
They have been approved for use by patients with melanoma and nonmelanoma skin cancer, according to the company.
The two Zeo skin care lines are the Zeocins and Zefs.
The third product is an anti-wrinkle drug called Rymosin.
Drs Ryns and Tomokos father is also the CEO of the European company Aetna, which also sells the product in Europe.
The U.K. drug company, Imperial Health, was recently acquired by Bayer HealthCare.
The Japanese company is owned and controlled by Eli Lilly and Company.